129 related articles for article (PubMed ID: 38598844)
1. Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer.
Grauers Wiktorin H; Aydin E; Kiffin R; Vilhav C; Bourghardt Fagman J; Kaya M; Paul S; Westman B; Bratlie SO; Naredi P; Hellstrand K; Martner A
Cancer Res Commun; 2024 Apr; 4(4):1135-1149. PubMed ID: 38598844
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
[TBL] [Abstract][Full Text] [Related]
3. CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
Choueiry F; Torok M; Shakya R; Agrawal K; Deems A; Benner B; Hinton A; Shaffer J; Blaser BW; Noonan AM; Williams TM; Dillhoff M; Conwell DL; Hart PA; Cruz-Monserrate Z; Bai XF; Carson WE; Mace TA
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581043
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.
Li C; Cui L; Yang L; Wang B; Zhuo Y; Zhang L; Wang X; Zhang Q; Zhang S
Pancreas; 2020 Jan; 49(1):120-127. PubMed ID: 31856087
[TBL] [Abstract][Full Text] [Related]
5. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
[TBL] [Abstract][Full Text] [Related]
6. Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species.
Akhiani AA; Hallner A; Kiffin R; Aydin E; Werlenius O; Aurelius J; Martner A; Thorén FB; Hellstrand K
Cancer Immunol Res; 2020 Dec; 8(12):1532-1541. PubMed ID: 32967913
[TBL] [Abstract][Full Text] [Related]
7. Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.
Metzger P; Kirchleitner SV; Boehmer DFR; Hörth C; Eisele A; Ormanns S; Gunzer M; Lech M; Lauber K; Endres S; Duewell P; Schnurr M; König LM
Cancer Immunol Immunother; 2020 Oct; 69(10):2101-2112. PubMed ID: 32448983
[TBL] [Abstract][Full Text] [Related]
8. Role of NOX2-Derived Reactive Oxygen Species in NK Cell-Mediated Control of Murine Melanoma Metastasis.
Aydin E; Johansson J; Nazir FH; Hellstrand K; Martner A
Cancer Immunol Res; 2017 Sep; 5(9):804-811. PubMed ID: 28760732
[TBL] [Abstract][Full Text] [Related]
9. Expression of H
Alvear-Arias JJ; Carrillo C; Villar JP; Garcia-Betancourt R; Peña-Pichicoi A; Fernandez A; Fernandez M; Carmona EM; Pupo A; Neely A; Alvarez O; Garate J; Barajas-Martinez H; Larsson HP; Lopez-Rodriguez A; Latorre R; Gonzalez C
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2104453119. PubMed ID: 35377790
[TBL] [Abstract][Full Text] [Related]
10. Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.
Oweida AJ; Mueller AC; Piper M; Milner D; Van Court B; Bhatia S; Phan A; Bickett T; Jordan K; Proia T; Schulick R; Messersmith WA; Del Chiaro M; Clambey E; Gough MJ; Williams J; Hansen K; Goodman K; Karam SD
Cancer Immunol Immunother; 2021 Apr; 70(4):989-1000. PubMed ID: 33097963
[TBL] [Abstract][Full Text] [Related]
11. Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity.
Tumino N; Besi F; Martini S; Di Pace AL; Munari E; Quatrini L; Pelosi A; Fiore PF; Fiscon G; Paci P; Scordamaglia F; Covesnon MG; Bogina G; Mingari MC; Moretta L; Vacca P
Front Immunol; 2021; 12():803014. PubMed ID: 35116033
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma.
Xiang H; Ramil CP; Hai J; Zhang C; Wang H; Watkins AA; Afshar R; Georgiev P; Sze MA; Song XS; Curran PJ; Cheng M; Miller JR; Sun D; Loboda A; Jia Y; Moy LY; Chi A; Brandish PE
Cancer Immunol Res; 2020 Apr; 8(4):436-450. PubMed ID: 32075803
[TBL] [Abstract][Full Text] [Related]
13. NOX2-Derived Reactive Oxygen Species in Cancer.
Grauers Wiktorin H; Aydin E; Hellstrand K; Martner A
Oxid Med Cell Longev; 2020; 2020():7095902. PubMed ID: 33312338
[TBL] [Abstract][Full Text] [Related]
14. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.
Murakami S; Shahbazian D; Surana R; Zhang W; Chen H; Graham GT; White SM; Weiner LM; Yi C
Oncogene; 2017 Mar; 36(9):1232-1244. PubMed ID: 27546622
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
Arnoletti JP; Reza J; Rosales A; Monreal A; Fanaian N; Whisner S; Srivastava M; Rivera-Otero J; Yu G; Phanstiel Iv O; Altomare DA; Tran Q; Litherland SA
PLoS One; 2022; 17(3):e0265725. PubMed ID: 35316296
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of Natural Killer cell cytotoxicity.
Tai LH; Alkayyal AA; Leslie AL; Sahi S; Bennett S; Tanese de Souza C; Baxter K; Angka L; Xu R; Kennedy MA; Auer RC
Oncoimmunology; 2018; 7(6):e1431082. PubMed ID: 29872554
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.
Song J; Lee J; Kim J; Jo S; Kim YJ; Baek JE; Kwon ES; Lee KP; Yang S; Kwon KS; Kim DU; Kang TH; Park YY; Chang S; Cho HJ; Kim SC; Koh SS; Kim S
Oncotarget; 2016 Aug; 7(32):51840-51853. PubMed ID: 27322081
[TBL] [Abstract][Full Text] [Related]
18. Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity.
Stromnes IM; Brockenbrough JS; Izeradjene K; Carlson MA; Cuevas C; Simmons RM; Greenberg PD; Hingorani SR
Gut; 2014 Nov; 63(11):1769-81. PubMed ID: 24555999
[TBL] [Abstract][Full Text] [Related]
19. Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma.
Yang C; Cheng H; Zhang Y; Fan K; Luo G; Fan Z; Huang Q; Lu Y; Jin K; Wang Z; Yu X; Liu C
Cancer Immunol Immunother; 2018 Dec; 67(12):1815-1823. PubMed ID: 30167864
[TBL] [Abstract][Full Text] [Related]
20. CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid-derived suppressor cells.
Gu H; Deng W; Zheng Z; Wu K; Sun F
Immun Inflamm Dis; 2021 Dec; 9(4):1686-1695. PubMed ID: 34525267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]